Thus, our findings confirm that, regardless of the nature of cell lines, induction of antiproliferation by promoting cyclin D1 proteasomal degradation is a universal mechanism or action underlying obatoclax-mediated anti-colon cancer activity. The gene discussed is CCND1; the disease is malignant colon neoplasm.